Literature DB >> 31456179

Breast Cancer: Current Perspectives on the Disease Status.

Mohammad Fahad Ullah1.   

Abstract

Breast cancer is the most frequently diagnosed cancer in women and ranks second among causes for cancer related death in women. Evidence in literature has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast cancer. This has been attributed to the progress made in the realm of screening, diagnosis and therapeutic strategies engaged in breast cancer management. However, poor prognosis in TNBC and drug resistance presents major inhibitions which are also current challenges for containing the disease. Similarly, a focal point of concern is the rising rate of breast cancer incidence and mortality among the population of under developed world. In this chapter, an overview of the current practices for the diagnosis and treatment of breast cancer and associated impediments has been provided.

Entities:  

Keywords:  Basal like; Breast carcinoma; Drug resistance; Endocrine therapy; Metastasis

Mesh:

Year:  2019        PMID: 31456179     DOI: 10.1007/978-3-030-20301-6_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  99 in total

1.  Effect of hypnosis before general anesthesia on postoperative outcomes in patients undergoing minor surgery for breast cancer: a systematic review and meta-analysis.

Authors:  Jing Zeng; Liang Wang; Qinfeng Cai; Jiaying Wu; Caishan Zhou
Journal:  Gland Surg       Date:  2022-03

2.  Effects of evidence-based nursing on psychological well-being, postoperative complications and quality of life after breast cancer surgery.

Authors:  Ying Li; Xiaofei Zhang; Lufei Zhang; Wei Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Changes of EGFR and SMC4 expressions in triple-negative breast cancer and their early diagnostic value.

Authors:  Ting Huang; Jing Xiang; Yun Wang; Youlin Tuo
Journal:  Gland Surg       Date:  2021-03

4.  Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.

Authors:  Zeyu Xing; Menglu Zhang; Xin Wang; Jiaqi Liu; Gang Liu; Kexin Feng; Xiang Wang
Journal:  J Mol Histol       Date:  2021-05-19       Impact factor: 2.611

Review 5.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

6.  Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1.

Authors:  Yu Wang; Peihong Zhou; Ping Li; Fengxia Yang; Xue-Qiang Gao
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

7.  Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors.

Authors:  Qi-Fang Liu; Zi-Yi Feng; Li-Li Jiang; Tong-Tong Xu; Si-Man Li; Kui-Ran Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17

8.  The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.

Authors:  Lu Zhao; Shuang Han; Junde Hou; Wenhui Shi; Yonglei Zhao; Yongxue Chen
Journal:  Aging (Albany NY)       Date:  2021-06-14       Impact factor: 5.682

9.  Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2.

Authors:  Bo-Wei Wang; Chih-Hao Huang; Liang-Chih Liu; Fang-Ju Cheng; Ya-Ling Wei; Yueh-Ming Lin; Yu-Fei Wang; Ching-Ting Wei; Yeh Chen; Yun-Ju Chen; Wei-Chien Huang
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

Review 10.  Role of Calixarene in Chemotherapy Delivery Strategies.

Authors:  Rossella Basilotta; Deborah Mannino; Alessia Filippone; Giovanna Casili; Angela Prestifilippo; Lorenzo Colarossi; Gabriele Raciti; Emanuela Esposito; Michela Campolo
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.